Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.15

+2.5%

Jan 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Harold Engstrom who wrote (7562)	12/20/2002 1:14:08 PM
From: Michael Young	Read Replies (1) of 52153

I've been following DOVP closely since the summer. I believe they may have three drugs in Phase III next year, including indiplon. The other drugs appear to address decent size markets, but I'm not sure about the odds of success. The stock would probably be trading over $10 but for the IPO fiasco. MIKE

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next